GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); September 26, 2023 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical…